John Valliant's Insider Trades & SAST Disclosures

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2024	320,400	320,400	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2024	192,200	192,200	-		-	Restricted Stock Units
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jan 2023	500,000	500,000	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.03 per share.	25 Apr 2022	4,511	318,147	-	6.0	27,201	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.07 per share.	25 Apr 2022	2,147	322,658	-	6.1	13,032	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.03 per share.	25 Apr 2022	2,036	324,805	-	6.0	12,277	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.10 per share.	11 Apr 2022	18,255	340,124	-	7.1	129,611	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.41 per share.	11 Apr 2022	11,994	328,130	-	6.4	76,882	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.37 per share.	11 Apr 2022	2,600	358,379	-	7.4	19,162	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.56 per share.	06 Apr 2022	1,255	361,805	-	7.6	9,488	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.52 per share.	06 Apr 2022	826	360,979	-	7.5	6,212	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.58 per share.	06 Apr 2022	100	363,060	-	7.6	758	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.67 per share.	01 Apr 2022	2,100	363,160	-	7.7	16,107	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.75 per share.	01 Apr 2022	1,000	365,960	-	7.8	7,750	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.81 per share.	01 Apr 2022	700	365,260	-	7.8	5,467	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.52 per share.	30 Mar 2022	300	366,960	-	7.5	2,256	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.55 per share.	25 Mar 2022	9,600	367,460	-	7.6	72,480	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.42 per share.	25 Mar 2022	500	377,060	-	7.4	3,710	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.52 per share.	25 Mar 2022	200	367,260	-	7.5	1,504	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.53 per share.	22 Mar 2022	4,000	378,360	-	7.5	30,120	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.46 per share.	22 Mar 2022	700	377,560	-	7.5	5,222	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.50 per share.	22 Mar 2022	100	378,260	-	7.5	750	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.47 per share.	17 Mar 2022	1,500	382,360	-	7.5	11,205	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.61 per share.	17 Mar 2022	1,204	383,860	-	7.6	9,162	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.51 per share.	17 Mar 2022	900	385,064	-	7.5	6,759	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.96 per share.	14 Mar 2022	1,300	386,164	-	7.0	9,048	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.99 per share.	14 Mar 2022	100	385,964	-	7.0	699	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.12 per share.	14 Mar 2022	100	386,064	-	7.1	712	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.06 per share.	09 Mar 2022	1,900	387,564	-	7.1	13,414	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.94 per share.	09 Mar 2022	822	389,464	-	6.9	5,705	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.13 per share.	09 Mar 2022	100	387,464	-	7.1	713	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.32 per share.	04 Mar 2022	8,400	396,390	-	7.3	61,488	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.99 per share.	04 Mar 2022	3,100	393,290	-	7.0	21,669	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.92 per share.	04 Mar 2022	3,004	390,286	-	6.9	20,788	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.44 per share.	01 Mar 2022	26,546	404,990	-	7.4	197,502	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.37 per share.	01 Mar 2022	847	431,536	-	7.4	6,242	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.28 per share.	01 Mar 2022	200	404,790	-	7.3	1,456	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.57 per share.	24 Feb 2022	8,152	435,483	-	7.6	61,711	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.40 per share.	24 Feb 2022	3,100	432,383	-	7.4	22,940	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.41 per share.	24 Feb 2022	2,500	443,635	-	7.4	18,525	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.77 per share.	18 Feb 2022	29,299	446,135	-	7.8	227,653	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.88 per share.	18 Feb 2022	4,898	479,534	-	7.9	38,596	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.85 per share.	18 Feb 2022	4,100	475,434	-	7.9	32,185	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.99 per share.	15 Feb 2022	33,202	486,132	-	8.0	265,284	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 8.33 per share.	15 Feb 2022	12,600	519,334	-	8.3	104,958	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.98 per share.	15 Feb 2022	1,700	484,432	-	8.0	13,566	Common Stock
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2022	406,600	406,600	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Feb 2021	336,000	336,000	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2020	372,948	372,948	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2020	206,541	206,541	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	John Valliant	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2020	173,528	173,528	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades